Role of Calcitonin in Managing Fracture Pain
Introduction to Calcitonin Therapy
- Calcitonin is effective for treating acute pain associated with osteoporotic vertebral compression fractures, with a recommended dose of 200 IU daily as nasal spray for 4 weeks, according to the American College of Physicians 1
Dosing and Administration
- For acute osteoporotic spinal compression fractures, the recommended dose is 200 IU daily for 4 weeks, administered as nasal spray, as suggested by the American Geriatrics Society 1
- Alternative administration routes include 100 IU subcutaneously or intramuscularly every other day, as recommended by the American College of Physicians 1
- Treatment should be initiated within 0-5 days after the onset of symptoms for optimal effect, according to the American Academy of Orthopaedic Surgeons 1
- Calcium and vitamin D supplementation should be given concurrently with calcitonin therapy, as advised by the National Osteoporosis Foundation 1
Patient Selection and Monitoring
- Yearly bone mineral density (BMD) measurements are recommended while on treatment to monitor response, as suggested by the International Osteoporosis Foundation 3
- If BMD falls >4% per year for two successive years, treatment should be changed to another agent, according to the National Institute on Aging 3
Side Effects and Safety
- Hypersensitivity reactions are rare but constitute a contraindication to calcitonin use, as warned by the American Academy of Allergy, Asthma, and Immunology 2
Limitations and Considerations
- For osteoporotic bone pain management, other options include bisphosphonates and denosumab, which are preferred for multifocal bone pain in cancer patients, as recommended by the American Geriatrics Society 4